Can NMR solve some significant challenges in metabolomics?

Journal of Magnetic Resonance

Volumn 260, Issue , 2015, Pages 144-160

  Nagana Gowda, G A ^a   Raftery, Daniel ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Biomarker discovery; Isotope tagging; Metabolomics; qNMR; Quantitation; Unknown metabolite identification

Indexed keywords

BIOMOLECULES; DRUG PRODUCTS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BIO-MARKER DISCOVERY; BIOLOGICAL SAMPLES; ENVIRONMENTAL SCIENCE; FUNDAMENTAL STUDIES; LIMITED SENSITIVITY; METABOLITE PROFILES; QUANTITATIVE ACCURACY; UNKNOWN IDENTIFICATIONS;

METABOLITES;

BIOLOGICAL MARKER;

ANIMAL; HUMAN; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; REPRODUCIBILITY;

ANIMALS; BIOMARKERS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; REPRODUCIBILITY OF RESULTS;

EID: 84959442983     PISSN: 10907807     EISSN: 10960856     Source Type: Journal    
DOI: 10.1016/j.jmr.2015.07.014     Document Type: Article

References (119)

1. Lindon, J.C., Nicholson, J.K., The emergent role of metabolic phenotyping in dynamic patient stratification. Expert Opin. Drug Metab. Toxicol. 10 (2014), 915–919.
2. Rhee, E.P., Gerszten, R.E., Metabolomics and cardiovascular biomarker discovery. Clin. Chem. 58 (2012), 139–147.
3. Griffin, J.L., Atherton, H., Shockcor, J., Atzori, L., Metabolomics as a tool for cardiac research. Nat. Rev. Cardiol. 8 (2011), 630–643.
4. Nagana Gowda, G.A., Raftery, D., Biomarker discovery and translation in metabolomics. Curr. Metabolomics 1 (2013), 227–240.
5. Dang, N.H., Singla, A.K., Mackay, E.M., Jirik, F.R., Weljie, A.M., Targeted cancer therapeutics: biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors. Curr. Pharm. Des. 20 (2014), 2637–2647.
6. Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., Bouatra, S., Sinelnikov, I., Arndt, D., Xia, J., Liu, P., Yallou, F., Bjorndahl, T., Perez-Pineiro, R., Eisner, R., Allen, F., Neveu, V., Greiner, R., Scalbert, A., HMDB 3.0 – the human metabolome database in 2013. Nucleic Acids Res. 41 (2013), D801–D807.
7. Nagana Gowda, G.A., Zhang, S., Gu, H., Asiago, V., Shanaiah, N., Raftery, D., Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn. 8 (2008), 617–633.
8. Nagana Gowda, G.A., Raftery, D., Advances in NMR based metabolomics. Simó, Carolina, Cifuentes, Alejandro, García-Cañas, Virginia, (eds.) Fundamentals of Advanced Omics Technologies: From Genes to Metabolites, Comprehensive Analytical Chemistry, vol. 63, 2014, Elsevier, New York, 187–211 (Chapter 8).
9. Bingol, K., Brüschweiler, R., Multidimensional approaches to NMR-based metabolomics. Anal. Chem. 86 (2014), 47–57.
10. Larive, C.K., Barding, G.A. Jr., Dinges, M.M., NMR spectroscopy for metabolomics and metabolic profiling. Anal. Chem. 87 (2015), 133–146.
11. Powers, R., The current state of drug discovery and a potential role for NMR metabolomics. J. Med. Chem. 57 (2014), 5860–5870.
12. Zhang, S., Nagana Gowda, G.A., Ye, T., Raftery, D., Advances in NMR based biofluid analysis and metabolite profiling. Analyst 135 (2010), 1490–1498.
13. Ye, T., Zhang, S., Nagana Gowda, G.A., Raftery, D., Nuclear magnetic resonance and statistical analysis. Meyers, R.A., (eds.) Encyclopedia of Analytical Chemistry, 2010, John Wiley, Hoboken, NJ.
14. 1H NMR studies on protein binding of histidine, tyrosine and phenylalanine in blood plasma. NMR Biomed. 2 (1989), 77–82.
15. Chatham, J.C., Forder, J.R., Lactic acid and protein interactions: implications for the NMR visibility of lactate in biological systems. Biochim. Biophys. Acta 1426 (1999), 177–184.
16. Daykin, C.A., Foxall, P.J., Connor, S.C., Lindon, J.C., Nicholson, J.K., The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy. Anal. Biochem. 304 (2002), 220–230.
17. Tiziani, S., Emwas, A.H., Lodi, A., Ludwig, C., Bunce, C.M., Viant, M.R., Günther, U.L., Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. Anal. Biochem. 377 (2008), 16–23.
18. Fan, T.W., The handbook of metabolomics. Fan, T.W., Higashi, R.M., Lane, A.N., (eds.) Methods in Pharmacology and Toxicology, 2012, Springer, New York, 7–27.
19. Serkova, N.J., Standiford, T.J., Stringer, K.A., The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am. J. Res. Crit. Care Med. 184 (2011), 647–655.
20. Simón-Manso, Y., Lowenthal, M.S., Kilpatrick, L.E., Sampson, M.L., Telu, K.H., Rudnick, P.A., Mallard, W.G., Bearden, D.W., Schock, T.B., Tchekhovskoi, D.V., Blonder, N., Yan, X., Liang, Y., Zheng, Y., Wallace, W.E., Neta, P., Phinney, K.W., Remaley, A.T., Stein, S.E., Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC–MS, LC–MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. Anal. Chem. 85 (2013), 11725–11731.
21. Psychogios, N., Hau, D.D., Peng, J., Guo, A.C., Mandal, R., Bouatra, S., Sinelnikov, I., Krishnamurthy, R., Eisner, R., Gautam, B., Young, N., Xia, J., Knox, C., Dong, E., Huang, P., Hollander, Z., Pedersen, T.L., Smith, S.R., Bamforth, F., Greiner, R., McManus, B., Newman, J.W., Goodfriend, T., Wishart, D.S., The human serum metabolome. PLoS One, 6, 2011, e16957.
22. Nagana Gowda, G.A., Raftery, D., Quantitating metabolites in protein precipitated serum using NMR spectroscopy. Anal. Chem. 86 (2014), 5433–5440.
23. Nagana Gowda, G.A., Gowda, Y.N., Raftery, D., Expanding the limits of human blood metabolite quantitation using NMR spectroscopy. Anal. Chem. 87 (2015), 706–715.
24. Mo, H., Raftery, D., Solvent signal as an NMR concentration reference. Anal. Chem. 80 (2008), 9835–9839.
25. Mo, H., Harwood, J.S., Zhang, S., Xue, Y., Santini, R., Raftery, D., A quantitative measure of NMR signal receiving efficiency. J. Magn. Reson. 200 (2009), 239–244.
26. Mo, H., Harwood, J.S., Raftery, D., Receiver gain function: the actual NMR receiver gain. Magn. Reson. Chem. 48 (2010), 235–238.
27. Mo, H., Harwood, J.S., Raftery, D., A quick diagnostic test for NMR receiver gain compression. Magn. Reson. Chem. 48:10 (2010), 782–786.
28. Lewis, A., Schommer, S.C., Hodis, B., Robb, K.A., Tonelli, M., Westler, W.M., Sussman, M.R., Markley, J.L., Method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H–13C NMR spectra. Anal. Chem. 79 (2007), 9385–9390.
29. Rai, R.K., Tripathi, P., Sinha, N., Quantification of metabolites from two-dimensional nuclear magnetic resonance spectroscopy: application to human urine samples. Anal. Chem. 81 (2009), 10232–10238.
30. Hu, K., Westler, W.M., Markley, J.L., Simultaneous quantification and identification of individual chemicals in metabolite mixtures by two-dimensional extrapolated time-zero 1H–13C HSQC (HSQC0). J. Am. Chem. Soc. 133 (2011), 1662–1665.
31. Ye, T., Zheng, C., Zhang, S., Nagana Gowda, G.A., Vitek, O., Raftery, D., “Add to subtract”: a simple method to remove complex background signals from the 1H nuclear magnetic resonance spectra of mixtures. Anal. Chem. 84 (2012), 994–1002.
32. Dona, A.C., Jiménez, B., Schäfer, H., Humpfer, E., Spraul, M., Lewis, M.R., Pearce, J.T., Holmes, E., Lindon, J.C., Nicholson, J.K., Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal. Chem. 86 (2014), 9887–9894.
33. Sukumaran, D.K., Garcia, E., Hua, J., Tabaczynski, W., Odunsi, K., Andrews, C., Szyperski, T., Standard operating procedure for metabonomics studies of blood serum and plasma samples using a 1H NMR micro-flow probe. Magn. Reson. Chem. 47:Suppl. 1 (2009), S81–S85.
34. Hwang, T.L., Shaka, A.J., Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 112:2 (1995), 275–279.
35. Ogg, R.J., Kingsley, P.B., Taylor, J.S., WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J. Magn. Reson. B 104 (1994), 1–10.
36. Smith, L.M., Maher, A.D., Cloarec, O., Rantalainen, M., Tang, H., Elliott, P., Stamler, J., Lindon, J.C., Holmes, E., Nicholson, J.K., Statistical correlation and projection methods for improved information recovery from diffusion-edited NMR spectra of biological samples. Anal. Chem. 79 (2007), 5682–5689.
37. Mo, H., Raftery, D., Improved residual water suppression: WET180. J. Biomol. NMR 41 (2008), 105–111.
38. Mo, H., Raftery, D., Pre-SAT180, a simple and effective method for residual water suppression. J. Magn. Reson. 190 (2008), 1–6.
39. Ivanisevic, J., Zhu, Z.J., Plate, L., Tautenhahn, R., Chen, S., O'Brien, P.J., Johnson, C.H., Marletta, M.A., Patti, G.J., Siuzdak, G., Toward ’omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism. Anal. Chem. 85 (2013), 6876–6884.
40. Sandusky, P., Appiah-Amponsah, E., Raftery, D., Use of optimized 1D TOCSY NMR for improved quantitation and metabolomic analysis of biofluids. J. Biomol. NMR 49 (2011), 281–290.
41. Sandusky, P., Raftery, D., Use of selective TOCSY NMR experiments for quantifying minor components in complex mixtures: application to the metabonomics of amino acids in honey. Anal. Chem. 77 (2005), 2455–2463.
42. Sandusky, P., Raftery, D., Use of semiselective TOCSY and the Pearson correlation for the metabonomic analysis of biofluid mixtures: application to urine. Anal. Chem. 77 (2005), 7717–7723.
43. Appiah-Amponsah, E., Shanaiah, N., Nagana Gowda, G.A., Owusu-Sarfo, K., Ye, T., Raftery, D., Identification of 4-deoxythreonic acid present in human urine using HPLC and NMR techniques. J. Pharm. Biomed. Anal. 50 (2009), 878–885.
44. Emwas, A.-H., Luchinat, C., Turano, P., Tenori, L., Roy, R., Salek, R.M., Ryan, D., Merzaban, J.S., Kaddurah-Daouk, R., Zeri, A.C., Nagana Gowda, G.A., Raftery, D., Wang, Y., Brennan, L., Wishart, D.S., Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics 11:14 (2015), 872–894.
45. Assfalg, M., Bertini, I., Colangiuli, D., Luchinat, C., Schäfer, H., Schütz, B., Spraul, M., Evidence of different metabolic phenotypes in humans. Proc. Natl. Acad. Sci. USA 105 (2008), 1420–1424.
46. Rist, M.J., Muhle-Goll, C., Görling, B., Bub, A., Heissler, S., Watzl, B., Luy, B., Influence of freezing and storage procedure on human urine samples in NMR-based metabolomics. Metabolites 3 (2013), 243–258.
47. Asiago, V.M., Nagana Gowda, G.A., Zhang, S., Shanaiah, N., Clark, J., Raftery, D., Use of EDTA to minimize ionic strength dependent frequency shifts in the 1H NMR spectra of urine. Metabolomics 4 (2008), 328–336.
48. Bouatra, S., Aziat, F., Mandal, R., Guo, A.C., Wilson, M.R., Knox, C., Bjorndahl, T.C., Krishnamurthy, R., Saleem, F., Liu, P., Dame, Z.T., Poelzer, J., Huynh, J., Yallou, F.S., Psychogios, N., Dong, E., Bogumil, R., Roehring, C., Wishart, D.S., The human urine metabolome. PLoS One, 8, 2013, e73076.
49. Cui, Q., Lewis, I.A., Hegeman, A.D., Anderson, M.E., Li, J., Schulte, C.F., Westler, W.M., Eghbalnia, H.R., Sussman, M.R., Markley, J.L., Metabolite identification via the Madison metabolomics consortium database. Nat. Biotechnol. 26 (2008), 162–164.
50. Chikayama, E., Sekiyama, Y., Okamoto, M., Nakanishi, Y., Tsuboi, Y., Akiyama, K., Saito, K., Shinozaki, K., Kikuchi, J., Statistical indices for simultaneous large-scale metabolite detections for a single NMR spectrum. Anal. Chem. 82 (2010), 1653–1658.
51. Ulrich, E.L., Akutsu, H., Doreleijers, J.F., Harano, Y., Ioannidis, Y.E., Lin, J., Livny, M., Mading, S., Maziuk, D., Miller, Z., Nakatani, E., Schulte, C.F., Tolmie, D.E., Wenger, R.K., Yao, H.Y., Markley, J.L., BioMagResBank. Nucleic Acids Res. 36 (2008), D402–D408.
52. Akiyama, K., Chikayama, E., Yuasa, H., Shimada, Y., Tohge, T., Shinozaki, K., Hirai, M.Y., Sakurai, T., Kikuchi, J., Saito, K., PRIMe: a Web site that assembles tools for metabolomics and transcriptomics. In Silico Biol. 8 (2008), 339–345.
53. Xia, J., Bjorndahl, T.C., Tang, P., Wishart, D.S., MetaboMiner-semi-automated identification of metabolites from 2D NMR spectra of complex biofluids. BMC Bioinformatics, 9, 2008, 507.
54. Bingol, K., Li, D.W., Bruschweiler-Li, L., Cabrera, O., Megraw, T., Zhang, F., Bruschweiler, R., Unified and isomer-specific NMR metabolomics database for the accurate analysis of 13C–1H HSQC spectra. ACS Chem. Biol. 10 (2015), 452–459.
55. Chikayama, E., Suto, M., Nishihara, T., Shinozaki, K., Kikuchi, J., Systematic NMR analysis of stable isotope labeled metabolite mixtures in plant and animal systems: coarse grained views of metabolic pathways. PLoS One, 3, 2008, e3805.
56. Zhang, F., Brüschweiler, R., Robust deconvolution of complex mixtures by covariance TOCSY spectroscopy. Angew. Chem., Int. Ed. 46 (2007), 2639–2642.
57. Bingol, K., Brüschweiler, R., Deconvolution of chemical mixtures with high complexity by NMR consensus trace clustering. Anal. Chem. 83 (2011), 7412–7417.
58. Cloarec, O., Dumas, M.E., Craig, A., Barton, R.H., Trygg, J., Hudson, J., Blancher, C., Gauguier, D., Lindon, J.C., Holmes, E., Nicholson, J.K., Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal. Chem. 77 (2005), 1282–1289.
59. Alves, C., Rantalainen, M., Holmes, E., Nicholson, J.K., Ebbels, T.M., Analytic properties of statistical total correlation spectroscopy based information recovery in 1H NMR metabolic data sets. Anal. Chem. 81 (2009), 2075–2084.
60. Crockford, D.J., Holmes, E., Lindon, J.C., Plumb, R.S., Zirah, S., Bruce, S.J., Rainville, P., Stumpf, C.L., Nicholson, J.K., Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal. Chem. 78 (2006), 363–371.
61. Robinette, S.L., Lindon, J.C., Nicholson, J.K., Statistical spectroscopic tools for biomarker discovery and systems medicine. Anal. Chem. 85 (2013), 5297–5303.
62. 13C NMR metabolomics: applications at natural abundance. Anal. Chem. 86 (2014), 9242–9250.
63. Posma, J.M., Garcia-Perez, I., De Iorio, M., Lindon, J.C., Elliott, P., Holmes, E., Ebbels, T.M., Nicholson, J.K., Subset optimization by reference matching (STORM): an optimized statistical approach for recovery of metabolic biomarker structural information from 1H NMR spectra of biofluids. Anal. Chem. 84 (2012), 10694–10701.
64. 1H NMR spectral data to reduce interference and enhance robust biomarkers selection. Anal. Chem. 86 (2014), 5308–5315.
65. Brüschweiler, R., Zhang, F., Covariance nuclear magnetic resonance spectroscopy. J. Chem. Phys. 120 (2004), 5253–5260.
66. Wei, S., Zhang, J., Liu, L., Ye, T., Nagana Gowda, G.A., Tayyari, F., Raftery, D., Ratio analysis nuclear magnetic resonance spectroscopy for selective metabolite identification in complex samples. Anal. Chem. 83 (2011), 7616–7623.
67. Gu, H., Nagana Gowda, G.A., Neto, F.C., Raftery, D., RAMSY: ratio analysis of mass spectrometry to improve compound identification. Anal. Chem. 85 (2013), 10771–10779.
68. Fan, T.W., Lorkiewicz, P.K., Sellers, K., Moseley, H.N., Higashi, R.M., Lane, A.N., Stable isotope-resolved metabolomics and applications for drug development. Pharmacol. Ther. 133 (2012), 366–391.
69. Zhang, F., Bruschweiler-Li, L., Brüschweiler, R., High-resolution homonuclear 2D NMR of carbon-13 enriched metabolites and their mixtures. J. Magn. Reson. 225 (2012), 10–13.
70. Bingol, K., Zhang, F., Bruschweiler-Li, L., Brüschweiler, R., Carbon backbone topology of the metabolome of a cell. J. Am. Chem. Soc. 134 (2012), 9006–9011.
71. Bingol, K., Zhang, F., Bruschweiler-Li, L., Brüschweiler, R., Quantitative analysis of metabolic mixtures by two-dimensional 13C constant-time TOCSY NMR spectroscopy. Anal. Chem. 85 (2013), 6414–6420.
72. Shanaiah, N., Desilva, A., Nagana Gowda, G.A., Raftery, M.A., Hainline, B.E., Raftery, D., Class selection of amino acid metabolites in body fluids using chemical derivatization and their enhanced 13C NMR. Proc. Natl. Acad. Sci. USA 104 (2007), 11540–11544.
73. Ye, T., Zhang, S., Mo, H., Tayyari, F., Nagana Gowda, G.A., Raftery, D., 13C-formylation for improved nuclear magnetic resonance profiling of amino metabolites in biofluids. Anal. Chem. 82 (2010), 2303–2309.
74. Ye, T., Mo, H., Shanaiah, N., Nagana Gowda, G.A., Zhang, S., Raftery, D., Chemoselective 15N tag for sensitive and high-resolution nuclear magnetic resonance profiling of the carboxyl-containing metabolome. Anal. Chem. 81 (2009), 4882–4888.
75. DeSilva, M.A., Shanaiah, N., Nagana Gowda, G.A., Rosa-Pérez, K., Hanson, B.A., Raftery, D., Application of 31P NMR spectroscopy and chemical derivatization for metabolite profiling of lipophilic compounds in human serum. Magn. Reson. Chem. Suppl. 1 (2009), S74–S80.
76. Nagana Gowda, G.A., Tayyari, F., Ye, T., Suryani, Y., Wei, S., Shanaiah, N., Raftery, D., Quantitative analysis of blood plasma metabolites using isotope enhanced NMR methods. Anal. Chem. 82 (2010), 8983–8990.
77. Tayyari, F., Nagana Gowda, G.A., Gu, H., Raftery, D., 15N-cholamine – a smart isotope tag for combining NMR- and MS-based metabolite profiling. Anal. Chem. 85 (2013), 8715–8721.
78. Lacey, M.E., Subramanian, R., Olson, D.L., Webb, A.G., Sweedler, J.V., High-resolution NMR spectroscopy of sample volumes from 1 nL to 10 μL. Chem. Rev. 99 (1999), 3133–3152.
79. Olson, D.L., Peck, T.L., Webb, A.G., Magin, R.L., Sweedler, J.V., High-resolution microcoil 1H NMR for mass-limited, nanoliter-volume samples. Science 270 (1995), 1967–1970.
80. Kc, R., Henry, I.D., Park, G.H.J., Raftery, D., Design and construction of a versatile dual volume heteronuclear double resonance microcoil NMR probe. J. Magn. Reson. 197 (2009), 186–192.
81. Kc, R., Gowda, Y.N., Djukovic, D., Henry, I.D., Park, G.H.J., Raftery, D., Susceptibility-matched plugs for microcoil NMR probes. J. Magn. Reson. 205 (2010), 63–68.
82. Ravi, K.C., Henry, I.D., Park, G.H.J., Aghdasi, A., Raftery, D., New solenoidal microcoil NMR probe using zero-susceptibility wire. Conc. Magn. Reson. Part B – Magn. Reson. Eng. 37B (2010), 13–19.
83. Grimes, J.H., O'Connell, T.M., The application of micro-coil NMR probe technology to metabolomics of urine and serum. J. Biomol. NMR 49 (2011), 297–305.
84. Bird, S.S., Sheldon, D.P., Gathungu, R.M., Vouros, P., Kautz, R., Matson, W.R., Kristal, B.S., Structural characterization of plasma metabolites detected via LC-electrochemical coulometric array using LC-UV fractionation, MS, and NMR. Anal. Chem. 84 (2012), 9889–9898.
85. Henry, D., Park, G.H.J., Kc, R., Tobias, B., Raftery, D., Design and construction of a microcoil NMR probe for the routine analysis of 20-μL samples. Conc. Magn. Reson. Part B – Magn. Reson. Eng. 33B (2008), 1–8.
86. Bergeron, S.J., Henry, I.D., Santini, R.E., Aghdasi, A., Raftery, D., Saturation transfer double-difference NMR spectroscopy using a dual solenoid microcoil difference probe. Magn. Reson. Chem. 46 (2008), 925–929.
87. Macnaughtan, M.A., Hou, T., Xu, J., Raftery, D., High-throughput nuclear magnetic resonance analysis using a multiple coil flow probe. Anal. Chem. 75 (2003), 5116–5123.
88. Cloarec, O., Campbell, A., Tseng, L.H., Braumann, U., Spraul, M., Scarfe, G., Weaver, R., Nicholson, J.K., Virtual chromatographic resolution enhancement in cryoflow LC-NMR experiments via statistical total correlation spectroscopy. Anal. Chem. 79 (2007), 3304–3311.
89. Lenz, E.M., Wilson, I.D., Analytical strategies in metabonomics. J. Proteome Res. 6 (2007), 443–458.
90. Djukovic, D., Liu, S., Henry, I., Tobias, B., Raftery, D., Signal enhancement in HPLC/microcoil NMR using automated column trapping. Anal. Chem. 78 (2006), 7154–7160.
91. Djukovic, D., Appiah-Amponsah, E., Shanaiah, N., Nagana Gowda, G.A., Henry, I., Everly, M., Tobias, B., Raftery, D., Ibuprofen metabolite profiling using a combination of SPE/column-trapping and HPLC-micro-coil NMR. J. Pharm. Biomed. Anal. 47 (2008), 328–334.
92. Garcia, E., Andrews, C., Hua, J., Kim, H.L., Sukumaran, D.K., Szyperski, T., Odunsi, K., Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe. J. Proteome Res. 10 (2011), 1765–1771.
93. Bhattacharya, P., Chekmenev, E.Y., Perman, W.H., Harris, K.C., Lin, A.P., Norton, V.A., Tan, C.T., Ross, B.D., Weitekamp, D.P., Towards hyperpolarized (13)C-succinate imaging of brain cancer. J. Magn. Reson. 186 (2007), 150–155.
94. Chekmenev, E.Y., Norton, V.A., Weitekamp, D.P., Bhattacharya, P., Hyperpolarized (1)H NMR employing low gamma nucleus for spin polarization storage. J. Am. Chem. Soc. 131 (2009), 3164–3165.
95. Shchepin, R.V., Coffey, A.M., Waddell, K.W., Chekmenev, E.Y., PASADENA hyperpolarized 13C phospholactate. J. Am. Chem. Soc. 134 (2012), 3957–3960.
96. Frydman, L., Blazina, D., Ultrafast two-dimensional nuclear magnetic resonance spectroscopy of hyperpolarized solutions. Nat. Phys. 3 (2007), 415–419.
97. Saunders, M.G., Ludwig, C., Gunther, U.L., Optimizing the signal enhancement in cryogenic ex situ DNP-NMR spectroscopy. J. Am. Chem. Soc. 130 (2008), 6914–6915.
98. Ardenkjaer-Larsen, J.H., Fridlund, B., Gram, A., Hansson, G., Hansson, L., Lerche, M.H., Servin, R., Thaning, M., Golman, K., Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc. Natl. Acad. Sci. USA 100 (2003), 10158–10163.
99. Kurhanewicz, J., Vigneron, D.B., Brindle, K., Chekmenev, E.Y., Comment, A., Cunningham, C.H., Deberardinis, R.J., Green, G.G., Leach, M.O., Rajan, S.S., Rizi, R.R., Ross, B.D., Warren, W.S., Malloy, C.R., Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 13 (2011), 81–97.
100. Giskeødegård, G.F., Cao, M.D., Bathen, T., High-resolution magic-angle-spinning NMR spectroscopy of intact tissue. Methods Mol. Biol. 1277 (2015), 37–50.
101. Wong, A., Jiménez, B., Li, X., Holmes, E., Nicholson, J.K., Lindon, J.C., Sakellariou, D., Evaluation of high resolution magic-angle coil spinning NMR spectroscopy for metabolic profiling of nanoliter tissue biopsies. Anal. Chem. 84 (2012), 3843–3848.
102. Choi, J.S., Baek, H.M., Kim, S., Kim, M.J., Youk, J.H., Moon, H.J., Kim, E.K., Han, K.H., Kim, D.H., Kim, S.I., Koo, J.S., HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors. PLoS One, 7, 2012, e51712.
103. Pan, Z., Gu, H., Talaty, N., Chen, H., Shanaiah, N., Hainline, B.E., Cooks, R.G., Raftery, D., Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Anal. Bioanal. Chem. 387 (2007), 539–549.
104. Gu, H., Pan, Z., Xi, B., Asiago, V., Musselman, B., Raftery, D., Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. Anal. Chim. Acta 686 (2011), 57–63.
105. Marshall, D.D., Lei, S., Worley, B., Huang, Y., Garcia-Garcia, A., Franco, R., Dodds, E.D., Powers, R., Combining DI-ESI-MS and NMR datasets for metabolic profiling. Metabolomics 11 (2015), 391–402.
106. Crockford, D.J., Maher, A.D., Ahmadi, K.R., Barrett, A., Plumb, R.S., Wilson, I.D., Nicholson, J.K., 1H NMR and UPLC-MS(E) statistical heterospectroscopy: characterization of drug metabolites (xenometabolome) in epidemiological studies. Anal. Chem. 80 (2008), 6835–6844.
107. Bingol, K., Bruschweiler-Li, L., Yu, C., Somogyi, A., Zhang, F., Brüschweiler, R., Metabolomics beyond spectroscopic databases: a combined MS/NMR strategy for the rapid identification of new metabolites in complex mixtures. Anal. Chem. 87 (2015), 3864–3870.
108. Serkova, N.J., Standiford, T.J., Stringer, K.A., The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am. J. Respir. Crit. Care Med. 184 (2011), 647–655.
109. Patel, N.R., McPhail, M.J., Shariff, M.I., Keun, H.C., Taylor-Robinson, S.D., Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology. Expert Rev. Gastroenterol. Hepatol. 6 (2012), 239–251.
110. Gika, H.G., Wilson, I.D., Global metabolic profiling for the study of alcohol-related disorders. Bioanalysis 6 (2014), 59–77.
111. Romick-Rosendale, L.E., Brunner, H.I., Bennett, M.R., Mina, R., Nelson, S., Petri, M., Kiani, A., Devarajan, P., Kennedy, M.A., Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis. Arthritis Res. Ther., 13, 2011, R199.
112. Wei, S., Suryani, Y., Nagana Gowda, G.A., Skill, N., Maluccio, M., Raftery, D., Differentiating hepatocellular carcinoma from hepatitis C using metabolite profiling. Metabolites 2 (2012), 701–716.
113. Owusu-Sarfo, K., Asiago, V.M., Deng, L., Gu, H., Wei, S., Shanaiah, N., Nagana Gowda, G.A., Xi, B., Chiorean, E.G., Raftery, D., NMR-based metabolite profiling of pancreatic cancer. Curr. Metabolomics 2 (2014), 204–212.
114. Asiago, V.M., Alvarado, L.Z., Shanaiah, N., Nagana Gowda, G.A., Owusu-Sarfo, K., Ballas, R.A., Raftery, D., Early detection of recurrent breast cancer using metabolite profiling. Cancer Res. 70 (2010), 8309–8318.
115. Wei, S., Liu, L., Zhang, J., Bowers, J., Nagana Gowda, G.A., Seeger, H., Fehm, T., Neubauer, H.J., Vogel, U., Clare, S.E., Raftery, D., Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Mol. Oncol. 7 (2013), 297–307.
116. Zhang, J., Bowers, J., Liu, L., Wei, S., Nagana Gowda, G.A., Hammoud, Z., Raftery, D., Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One, 7, 2012, e30181.
117. Zhang, J., Liu, L., Wei, S., Nagana Gowda, G.A., Hammoud, Z., Kessler, K.A., Raftery, D., Metabolomics study of esophageal adenocarcinoma. J. Thoracic Cardiovas. Surg. 141 (2011), 469–475.
118. Xia, J., Broadhurst, D.I., Wilson, M., Wishart, D.S., Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 9 (2013), 280–299.
119. Carrola, J., Rocha, C.M., Barros, A.S., Gil, A.M., Goodfellow, B.J., Carreira, I.M., Bernardo, J., Gomes, A., Sousa, V., Carvalho, L., Duarte, I.F., Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J. Proteome Res. 10 (2011), 221–230.